Citadel Advisors
BLUE

Citadel Advisors’s bluebird bio BLUE Stock Holding History

Citadel Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,390
Closed -$173K – 14264
2024
Q2 		$205K Sell
10,390
-57
-0.5% -$1.14K ﹤0.01% 9885
2024
Q1 		$267K Sell
10,447
-63,745
-86% -$1.63M ﹤0.01% 9720
2023
Q4 		$2.05M Buy
74,192
+35,073
+90% +$2.14M ﹤0.01% 5305
2023
Q3 		$2.38M Buy
39,119
+17,167
+78% +$1.21M ﹤0.01% 4906
2023
Q2 		$1.44M Sell
21,952
-87,117
-80% -$6.37M ﹤0.01% 5745
2023
Q1 		$6.94M Buy
109,069
+96,929
+798% +$11.1M ﹤0.01% 3294
2022
Q4 		$1.68M Sell
12,140
-34,857
-74% -$4.91M ﹤0.01% 5811
2022
Q3 		$5.95M Sell
46,997
-2,822
-6% -$319K ﹤0.01% 3579
2022
Q2 		$4.13M Buy
49,819
+41,713
+515% +$3.23M ﹤0.01% 4155
2022
Q1 		$786K Buy
8,106
+7,309
+917% +$965K ﹤0.01% 8255
2021
Q4 		$159K Sell
797
-1,065
-57% -$251K ﹤0.01% 12189
2021
Q3 		$461K Sell
1,862
-4,503
-71% -$1.29M ﹤0.01% 10071
2021
Q2 		$2.64M Buy
6,365
+3,139
+97% +$1.24M ﹤0.01% 5914
2021
Q1 		$1.26M Sell
3,226
-2,459
-43% -$1.21M ﹤0.01% 7528
2020
Q4 		$3.19M Sell
5,685
-15,525
-73% -$9.84M ﹤0.01% 4497
2020
Q3 		$14.8M Buy
21,210
+12,697
+149% +$9.9M ﹤0.01% 1849
2020
Q2 		$6.73M Sell
8,513
-73,794
-90% -$55.6M ﹤0.01% 2678
2020
Q1 		$49M Buy
82,307
+21,068
+34% +$20.5M 0.02% 655
2019
Q4 		$69.6M Buy
61,239
+44,447
+265% +$48.3M 0.03% 578
2019
Q3 		$20M Buy
16,792
+14,810
+747% +$22.6M 0.01% 1470
2019
Q2 		$3.27M Buy
1,982
+1,617
+443% +$2.8M ﹤0.01% 3724
2019
Q1 		$744K Buy
+365
New +$643K ﹤0.01% 6111
2018
Q4 		– Sell
-1,172
Closed -$1.8M – 9110
2018
Q3 		$2.22M Sell
1,172
-11,177
-91% -$23.1M ﹤0.01% 4228
2018
Q2 		$25.1M Buy
12,349
+9,046
+274% +$20.6M 0.01% 1133
2018
Q1 		$7.3M Sell
3,303
-3,123
-49% -$7.94M ﹤0.01% 2043
2017
Q4 		$14.8M Buy
6,426
+6,001
+1,412% +$12.2M 0.01% 1381
2017
Q3 		$757K Sell
425
-4,223
-91% -$5.9M ﹤0.01% 4720
2017
Q2 		$6.33M Buy
4,648
+4,150
+833% +$5.01M 0.01% 1873
2017
Q1 		$587K Buy
+498
New +$508K ﹤0.01% 4773
2016
Q4 		– Sell
-1,458
Closed -$1.16M – 7260
2016
Q3 		$1.28M Buy
+1,458
New +$1.06M ﹤0.01% 3515
2016
Q2 		– Sell
-2,141
Closed -$1.21M – 6832
2016
Q1 		$1.18M Buy
2,141
+434
+25% +$267K ﹤0.01% 3278
2015
Q4 		$1.42M Sell
1,707
-4,023
-70% -$4.02M ﹤0.01% 3161
2015
Q3 		$6.35M Buy
5,730
+5,136
+865% +$9.37M 0.01% 1702
2015
Q2 		$1.3M Sell
594
-14,250
-96% -$29M ﹤0.01% 3633
2015
Q1 		$23.2M Buy
14,844
+153
+1% +$202K 0.02% 899
2014
Q4 		$17.5M Buy
14,691
+8,782
+149% +$5.87M 0.02% 1032
2014
Q3 		$2.75M Buy
5,909
+5,432
+1,139% +$2.51M ﹤0.01% 2528
2014
Q2 		$239K Buy
+477
New +$153K ﹤0.01% 5359
2013
Q3 		– Sell
-3,859
Closed -$1.25M – 6732
2013
Q2 		$1.25M Buy
+3,859
New +$1.27M ﹤0.01% 2960

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's BLUE Position: Q3 2024 in Review

Citadel Advisors sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 10,390 shares — an estimated $173K sold.

Citadel Advisors first reported a position in BLUE in Q2 2013 and held it in 39 quarters. The position peaked at $69.6M in Q4 2019. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • Citadel Advisors reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 10,390 bluebird bio shares in Q3 2024, an estimated $173K.
  • Citadel Advisors first reported a position in bluebird bio in Q2 2013 and held it in 39 quarters.
  • Citadel Advisors's bluebird bio position peaked at $69.6M in Q4 2019.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.